Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trialJ H Scurr, Philip Smith, Samuel J. Machin et al.|The Lancet|2001Cited by 411
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trialHannah Cohen, David Isenberg, Simon Clawson et al.|The Lancet Haematology|2016Cited by 404
Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical featuresMarie Scully, Samuel J. Machin, Helen Yarranton et al.|British Journal of Haematology|2008Cited by 376
Guidelines on oral anticoagulation: third editionTrevor Baglin, Isobel D. Walker, Samuel J. Machin et al.|British Journal of Haematology|1998Cited by 316
Guidelines On The Investigation and Management Of The Antiphospholipid SyndromeM. Greaves, Ian Mackie, Hannah Cohen et al.|British Journal of Haematology|2000Cited by 297